Key facts
- HitGen (SHG: 688222) is a other based in Chengdu, Sichuan.
About HitGen (SHG: 688222)
HitGen Inc is engaged in drug research and development and provision of technical consultation, technology transfer, and technical services. The company uses DEL technology to provide research and development services for early drug discovery and transfer of new drug R&D projects.
Free account
See the whole book
- ·Watchlist + alerts for HitGen (SHG: 688222)'s activity
Create free account
No card required
Portfolio
Portfolio — not yet on record
No portfolio companies for HitGen (SHG: 688222) are on record yet. Positions surface from round participations, filings, and coverage.
Pro members can request priority coverage with a 48-hour turnaround.